Production (Stage)
Genocea Biosciences, Inc.
GNCAQ
$0.00
$0.000.00%
OTC PK
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 270.00K | 0.00 | 1.64M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 270.00K | 0.00 | 1.64M | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 270.00K | 0.00 | 1.64M | -- | -- |
| SG&A Expenses | 3.60M | 3.13M | 3.88M | 4.03M | 3.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.04M | 14.51M | 13.36M | 14.55M | 12.42M |
| Operating Income | -15.77M | -14.51M | -11.72M | -14.55M | -12.42M |
| Income Before Tax | -15.98M | -13.28M | -3.62M | -4.31M | -11.98M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.98M | -13.28M | -3.62M | -4.31M | -11.98M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.98M | -13.28M | -3.62M | -4.31M | -11.98M |
| EBIT | -15.77M | -14.51M | -11.72M | -14.55M | -12.42M |
| EBITDA | -15.37M | -14.29M | -11.32M | -14.18M | -12.04M |
| EPS Basic | -0.22 | -0.19 | -0.05 | -0.06 | -0.18 |
| Normalized Basic EPS | -0.14 | -0.13 | -0.03 | -0.04 | -0.11 |
| EPS Diluted | -0.22 | -0.19 | -0.05 | -0.21 | -0.18 |
| Normalized Diluted EPS | -0.14 | -0.13 | -0.03 | -0.04 | -0.11 |
| Average Basic Shares Outstanding | 71.12M | 70.40M | 69.81M | 67.97M | 66.16M |
| Average Diluted Shares Outstanding | 71.12M | 70.40M | 69.81M | 70.20M | 66.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |